Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Common Equity (2016 - 2025)

Nu-Med Plus' Common Equity history spans 11 years, with the latest figure at -$132358.0 for Q4 2021.

  • On a quarterly basis, Common Equity fell 128.3% to -$132358.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$132358.0, a 128.3% decrease, with the full-year FY2021 number at -$132358.0, down 128.3% from a year prior.
  • Common Equity hit -$132358.0 in Q4 2021 for Nu-Med Plus, down from -$70017.0 in the prior quarter.
  • Over the last five years, Common Equity for NUMD hit a ceiling of $467703.0 in Q4 2020 and a floor of -$370432.0 in Q4 2019.
  • Historically, Common Equity has averaged -$15423.6 across 5 years, with a median of -$22926.5 in 2018.
  • Biggest five-year swings in Common Equity: skyrocketed 332.43% in 2018 and later tumbled 1137.48% in 2019.
  • Tracing NUMD's Common Equity over 5 years: stood at $68242.0 in 2017, then fell by 28.89% to $48527.0 in 2018, then plummeted by 863.35% to -$370432.0 in 2019, then soared by 226.26% to $467703.0 in 2020, then plummeted by 128.3% to -$132358.0 in 2021.
  • Business Quant data shows Common Equity for NUMD at -$132358.0 in Q4 2021, -$70017.0 in Q3 2021, and -$1651.0 in Q2 2021.